» Articles » PMID: 27293512

Extracellular Superoxide Dismutase: Growth Promoter or Tumor Suppressor?

Overview
Publisher Wiley
Date 2016 Jun 14
PMID 27293512
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Extracellular superoxide dismutase (SOD3) gene transfer to tissue damage results in increased healing, increased cell proliferation, decreased apoptosis, and decreased inflammatory cell infiltration. At molecular level, in vivo SOD3 overexpression reduces superoxide anion (O2 (-)) concentration and increases mitogen kinase activation suggesting that SOD3 could have life-supporting characteristics. The hypothesis is further strengthened by the observations showing significantly increased mortality in conditional knockout mice. However, in cancer SOD3 has been shown to either increase or decrease cell proliferation and survival depending on the model system used, indicating that SOD3-derived growth mechanisms are not completely understood. In this paper, the author reviews the main discoveries in SOD3-dependent growth regulation and signal transduction.

Citing Articles

Copper-Based Nanomedicines for Cuproptosis-Mediated Effective Cancer Treatment.

Noh D, Lee H, Lee S, Sun I, Yoon H Biomater Res. 2024; 28:0094.

PMID: 39430913 PMC: 11486892. DOI: 10.34133/bmr.0094.


Role of copper and SOD3-mediated extracellular redox regulation in tumor progression.

Kamiya T J Clin Biochem Nutr. 2024; 75(1):1-6.

PMID: 39070539 PMC: 11273271. DOI: 10.3164/jcbn.24-14.


Inflammation-Associated Cytotoxic Agents in Tumorigenesis.

Arnhold J Cancers (Basel). 2024; 16(1).

PMID: 38201509 PMC: 10778456. DOI: 10.3390/cancers16010081.


Abnormalities in Copper Status Associated with an Elevated Risk of Parkinson's Phenotype Development.

Karpenko M, Muruzheva Z, Ilyechova E, Babich P, Puchkova L Antioxidants (Basel). 2023; 12(9).

PMID: 37759957 PMC: 10525645. DOI: 10.3390/antiox12091654.


NLRX1 functions as a tumor suppressor in Pan02 pancreatic cancer cells.

Nagai-Singer M, Morrison H, Woolls M, Leedy K, Imran K, Tupik J Front Oncol. 2023; 13:1155831.

PMID: 37342194 PMC: 10277690. DOI: 10.3389/fonc.2023.1155831.


References
1.
Ozumi K, Tasaki H, Takatsu H, Nakata S, Morishita T, Koide S . Extracellular superoxide dismutase overexpression reduces cuff-induced arterial neointimal formation. Atherosclerosis. 2005; 181(1):55-62. DOI: 10.1016/j.atherosclerosis.2005.01.051. View

2.
Marklund S . Human copper-containing superoxide dismutase of high molecular weight. Proc Natl Acad Sci U S A. 1982; 79(24):7634-8. PMC: 347402. DOI: 10.1073/pnas.79.24.7634. View

3.
Qian Z, Haessler M, Lemos J, Arsenault J, Aguirre J, Gilbert J . Targeting vascular injury using Hantavirus-pseudotyped lentiviral vectors. Mol Ther. 2006; 13(4):694-704. DOI: 10.1016/j.ymthe.2005.11.016. View

4.
Abdel-Mageed A, Senagore A, Pietryga D, Connors R, Giambernardi T, Hay R . Intravenous administration of mesenchymal stem cells genetically modified with extracellular superoxide dismutase improves survival in irradiated mice. Blood. 2009; 113(5):1201-3. DOI: 10.1182/blood-2008-07-170936. View

5.
Di Micco R, Fumagalli M, dAdda di Fagagna F . Breaking news: high-speed race ends in arrest--how oncogenes induce senescence. Trends Cell Biol. 2007; 17(11):529-36. DOI: 10.1016/j.tcb.2007.07.012. View